US Stock MarketDetailed Quotes

Protalix Biotherapeutics (PLX)

Watchlist
  • 3.000
  • -0.140-4.46%
Close Feb 24 16:00 ET
  • 3.040
  • +0.040+1.33%
Post 20:01 ET
241.26MMarket Cap37.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protalix Biotherapeutics (PLX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Revenue from selling goods17.67M99.00%
Revenue from license and research and development (R&D) services178K1.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
Israel53.4M100.00%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +7.46%
Sample Name
Sample Code
 +4.07%
Sample Name
Sample Code
 +3.85%
4
Qualcomm
QCOM
+3.11%
5
Netflix
NFLX
+2.66%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +7.72%
Sample Name
Sample Code
 +7.68%
Sample Name
Sample Code
 +6.33%
4
Taiwan Semiconductor
TSM
+5.92%
5
ASE Technology
ASX
+5.75%
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More
Is the US stock market entering a recovery phase? Trump and Jensen Huang both 'chiming in' with these three key trends worth watching!
Wait for the right moment to act

- No more -